MEREO BIOPHARMA GROUP PLC
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2022 | $-48.8M | $-48.8M | $13.0K | $4.8M |
| FY2023 | $-21.1M | $-21.1M | $0 | $4.9M |
| FY2024 | $-32.8M | $-32.8M | $0 | $7.4M |
| FY2025 | $-31.0M | $-31.0M | $20.0K | $7.6M |